Market Cap 1.43B
Revenue (ttm) 0.00
Net Income (ttm) -287.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.15
Volume 4,135,100
Avg Vol 4,020,922
Day's Range N/A - N/A
Shares Out 134.95M
Stochastic %K 37%
Beta 2.39
Analysts Strong Sell
Price Target $21.97

Company Profile

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 44 716 6766461
Address:
33 Broadwick Street, London, United Kingdom
Skidit100
Skidit100 May. 20 at 4:12 AM
$CMPS The vast majority of analysts including firms like TD Cowen, Jefferies, and Morgan Stanley model the baseline peak sales average right around $2 billion. These kids in the chat are just lightweights
1 · Reply
nope45
nope45 May. 20 at 2:19 AM
$CMPS I’ll wait for the $6.66 gap to add calls
1 · Reply
Waldo_5150
Waldo_5150 May. 19 at 11:23 PM
$CMPS ..... Compass is a U.K. London Company - FDA approval = E.U. approval. .
0 · Reply
Millionaire11
Millionaire11 May. 19 at 10:42 PM
Never said it was easy 🤡🤡🤡 $CMPS @DeepValueStocks google this. What puts compass ahead of most biotechs in the R&D space right now? Why will they succeed? You can prompt AI to give you any answer you want. You’re delusional and don’t realize AI feeds you what you already believe based off how you prompt it. 🤡 🤡🤡
0 · Reply
Millionaire11
Millionaire11 May. 19 at 8:46 PM
$CMPS bears are coming out. Know what you hold. Trust your Due Diligence! God knows. Trust
0 · Reply
DeepValueStocks
DeepValueStocks May. 19 at 6:58 PM
$CMPS Google the question below and read the answers. The answers are why the stock is declining: Why do some analysts and critics argue that CMPS' treatment-resistant depression drug (COMP360) could struggle commercially due to an overwhelming financial and logistical burden ? Take the money and run
3 · Reply
Millionaire11
Millionaire11 May. 19 at 4:49 PM
$CMPS since everyone is talking about buyouts. $CMPS is actually expected to do peak sales of $1.5-2.3 billion dollars in sales per year. Based off previous posters multiples that puts this at 6-16 billion dollar BO price.
2 · Reply
HamBoneXoXo
HamBoneXoXo May. 19 at 4:41 PM
$CMPS Since everyone talking about buyouts, so why not me. 🤣😜😜 Evaluations at buyout are largely based on rev and cost and I saw a $300 mil peak sales from an analyst. If so, then a 4-7 multiplier puts a BO at $1.2-2.1 bil. Does that make sense? Waine says a target of 70 pps which I have no clue how they determined. Do you have better informed peak sales numbers? If not, find some before grabbing BO numbers from thin air.
4 · Reply
texmade2
texmade2 May. 19 at 4:15 PM
$CMPS nice , ready to run $13 $14
0 · Reply
Skidit100
Skidit100 May. 19 at 4:08 PM
$CMPS $CMPS this could quad or more from here in a buyout scenario which usually happens in biotech between last data and nda submission or very soon after approval. So potentially 6 months we could see this
0 · Reply
Latest News on CMPS
Compass Pathways Q1 Earnings Call Highlights

May 13, 2026, 10:08 AM EDT - 6 days ago

Compass Pathways Q1 Earnings Call Highlights


COMPASS Pathways Earnings Call Transcript: Q1 2026

May 13, 2026, 8:00 AM EDT - 6 days ago

COMPASS Pathways Earnings Call Transcript: Q1 2026


COMPASS Pathways Quarterly report: Q1 2026

May 13, 2026, 8:00 AM EDT - 6 days ago

COMPASS Pathways Quarterly report: Q1 2026


COMPASS Pathways Earnings release: Q1 2026

May 13, 2026, 8:00 AM EDT - 6 days ago

COMPASS Pathways Earnings release: Q1 2026


COMPASS Pathways Earnings release: Q1 2026

May 13, 2026, 8:00 AM EDT - 6 days ago

COMPASS Pathways Earnings release: Q1 2026


Compass Pathways reports Q1 EPS (30c), consensus (31c)

2026-05-13T11:23:45.000Z - 6 days ago

Compass Pathways reports Q1 EPS (30c), consensus (31c)


COMPASS Pathways Slides: Investor presentation

May 13, 2026, 7:00 AM EDT - 6 days ago

COMPASS Pathways Slides: Investor presentation


Compass Pathways initiated with a Buy at Jefferies

2026-05-03T23:55:09.000Z - 16 days ago

Compass Pathways initiated with a Buy at Jefferies

JNJ


COMPASS Pathways Transcript: Needham Virtual Psychedelics Forum

Apr 27, 2026, 11:00 AM EDT - 22 days ago

COMPASS Pathways Transcript: Needham Virtual Psychedelics Forum


Compass Pathways initiated with a Buy at B. Riley

2026-04-24T12:57:10.000Z - 25 days ago

Compass Pathways initiated with a Buy at B. Riley


Compass Pathways enters collaboration with Osmind

2026-04-21T10:54:16.000Z - 4 weeks ago

Compass Pathways enters collaboration with Osmind


This 4/20, Wall Street Is Betting on More Than Marijuana

Apr 20, 2026, 3:05 PM EDT - 4 weeks ago

This 4/20, Wall Street Is Betting on More Than Marijuana

ATAI


Psychedelic stocks rally with Trump's support

Apr 20, 2026, 8:26 AM EDT - 4 weeks ago

Psychedelic stocks rally with Trump's support

ATAI DFTX GHRS


COMPASS Pathways Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 4 weeks ago

COMPASS Pathways Proxy statement: Proxy filing


COMPASS Pathways Annual report: Q4 2025

Mar 24, 2026, 7:00 AM EDT - 2 months ago

COMPASS Pathways Annual report: Q4 2025


COMPASS Pathways Earnings release: Q4 2025

Mar 24, 2026, 7:00 AM EDT - 2 months ago

COMPASS Pathways Earnings release: Q4 2025


COMPASS Pathways Annual report: Q4 2025

Mar 24, 2026, 7:00 AM EDT - 2 months ago

COMPASS Pathways Annual report: Q4 2025


COMPASS Pathways Transcript: Stifel 2026 Virtual CNS Forum

Mar 18, 2026, 10:30 AM EDT - 2 months ago

COMPASS Pathways Transcript: Stifel 2026 Virtual CNS Forum


COMPASS Pathways Transcript: Study update

Feb 17, 2026, 8:00 AM EST - 3 months ago

COMPASS Pathways Transcript: Study update


COMPASS Pathways Press release: Study update

Feb 17, 2026, 8:00 AM EST - 3 months ago

COMPASS Pathways Press release: Study update


COMPASS Pathways Slides: Study update

Feb 17, 2026, 8:00 AM EST - 3 months ago

COMPASS Pathways Slides: Study update


COMPASS Pathways Transcript: KOL Event

Jan 7, 2026, 10:00 AM EST - 4 months ago

COMPASS Pathways Transcript: KOL Event


COMPASS Pathways Press release: KOL Event

Jan 7, 2026, 10:00 AM EST - 4 months ago

COMPASS Pathways Press release: KOL Event


COMPASS Pathways Slides: KOL Event

Jan 7, 2026, 10:00 AM EST - 4 months ago

COMPASS Pathways Slides: KOL Event


COMPASS Pathways Slides: Investor Presentation

Jan 7, 2026, 7:00 AM EST - 4 months ago

COMPASS Pathways Slides: Investor Presentation


COMPASS Pathways Transcript: Stifel 2025 Healthcare Conference

Nov 11, 2025, 10:40 AM EST - 6 months ago

COMPASS Pathways Transcript: Stifel 2025 Healthcare Conference


COMPASS Pathways Slides: Investor Presentation

Nov 4, 2025, 9:30 AM EST - 7 months ago

COMPASS Pathways Slides: Investor Presentation


COMPASS Pathways Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:00 AM EST - 7 months ago

COMPASS Pathways Earnings Call Transcript: Q3 2025


COMPASS Pathways Quarterly report: Q3 2025

Nov 4, 2025, 8:00 AM EST - 7 months ago

COMPASS Pathways Quarterly report: Q3 2025


COMPASS Pathways Earnings release: Q3 2025

Nov 4, 2025, 8:00 AM EST - 7 months ago

COMPASS Pathways Earnings release: Q3 2025


COMPASS Pathways Earnings Call Transcript: Q2 2025

Jul 31, 2025, 8:00 AM EDT - 10 months ago

COMPASS Pathways Earnings Call Transcript: Q2 2025


COMPASS Pathways Earnings release: Q2 2025

Jul 31, 2025, 8:00 AM EDT - 10 months ago

COMPASS Pathways Earnings release: Q2 2025


COMPASS Pathways Quarterly report: Q2 2025

Jul 31, 2025, 8:00 AM EDT - 10 months ago

COMPASS Pathways Quarterly report: Q2 2025


Compass Pathways Appoints Justin Gover to Board of Directors

Jul 29, 2025, 6:30 AM EDT - 10 months ago

Compass Pathways Appoints Justin Gover to Board of Directors


Compass Pathways' depression drug succeeds late-stage trial

Jun 23, 2025, 6:48 AM EDT - 11 months ago

Compass Pathways' depression drug succeeds late-stage trial


Skidit100
Skidit100 May. 20 at 4:12 AM
$CMPS The vast majority of analysts including firms like TD Cowen, Jefferies, and Morgan Stanley model the baseline peak sales average right around $2 billion. These kids in the chat are just lightweights
1 · Reply
nope45
nope45 May. 20 at 2:19 AM
$CMPS I’ll wait for the $6.66 gap to add calls
1 · Reply
Waldo_5150
Waldo_5150 May. 19 at 11:23 PM
$CMPS ..... Compass is a U.K. London Company - FDA approval = E.U. approval. .
0 · Reply
Millionaire11
Millionaire11 May. 19 at 10:42 PM
Never said it was easy 🤡🤡🤡 $CMPS @DeepValueStocks google this. What puts compass ahead of most biotechs in the R&D space right now? Why will they succeed? You can prompt AI to give you any answer you want. You’re delusional and don’t realize AI feeds you what you already believe based off how you prompt it. 🤡 🤡🤡
0 · Reply
Millionaire11
Millionaire11 May. 19 at 8:46 PM
$CMPS bears are coming out. Know what you hold. Trust your Due Diligence! God knows. Trust
0 · Reply
DeepValueStocks
DeepValueStocks May. 19 at 6:58 PM
$CMPS Google the question below and read the answers. The answers are why the stock is declining: Why do some analysts and critics argue that CMPS' treatment-resistant depression drug (COMP360) could struggle commercially due to an overwhelming financial and logistical burden ? Take the money and run
3 · Reply
Millionaire11
Millionaire11 May. 19 at 4:49 PM
$CMPS since everyone is talking about buyouts. $CMPS is actually expected to do peak sales of $1.5-2.3 billion dollars in sales per year. Based off previous posters multiples that puts this at 6-16 billion dollar BO price.
2 · Reply
HamBoneXoXo
HamBoneXoXo May. 19 at 4:41 PM
$CMPS Since everyone talking about buyouts, so why not me. 🤣😜😜 Evaluations at buyout are largely based on rev and cost and I saw a $300 mil peak sales from an analyst. If so, then a 4-7 multiplier puts a BO at $1.2-2.1 bil. Does that make sense? Waine says a target of 70 pps which I have no clue how they determined. Do you have better informed peak sales numbers? If not, find some before grabbing BO numbers from thin air.
4 · Reply
texmade2
texmade2 May. 19 at 4:15 PM
$CMPS nice , ready to run $13 $14
0 · Reply
Skidit100
Skidit100 May. 19 at 4:08 PM
$CMPS $CMPS this could quad or more from here in a buyout scenario which usually happens in biotech between last data and nda submission or very soon after approval. So potentially 6 months we could see this
0 · Reply
Irish_lass
Irish_lass May. 19 at 3:18 PM
$CMPS Added on the nice dip this morning. Take advantage when the XBI takes a dive.
0 · Reply
Millionaire11
Millionaire11 May. 19 at 2:55 PM
$CMPS bottoms in. Close near day high.
0 · Reply
Waldo_5150
Waldo_5150 May. 19 at 2:26 PM
$CMPS .... Market reaction dropping everything, Trumps trip to China was a useless photo op - Compass should hold $10.00 . ..
0 · Reply
shitstockfeok
shitstockfeok May. 19 at 2:05 PM
$CMPS Time to buy the dip with both hands
0 · Reply
Millionaire11
Millionaire11 May. 19 at 1:54 PM
$CMPS keep selling while smart money scoops shares. 1.4 billion market cap is nothing compared to where this is going
0 · Reply
Sndlisfake
Sndlisfake May. 19 at 12:39 PM
1 · Reply
Skidit100
Skidit100 May. 19 at 2:05 AM
$CMPS j&j sees compass as a threat to spravato, they will either buy them out or another one will which would create a bidding war. j&j doesn’t want competition from another big pharma this would create competition for their golden goose spravato which we now know is inferior to comp360
0 · Reply
texmade2
texmade2 May. 18 at 11:49 PM
$CMPS Breakout trade WATCH for possible breakout above 11.01 Target: 12.73
0 · Reply
Sauce27x
Sauce27x May. 18 at 10:53 PM
$CMPS Johnson gonna buy out Cmps
0 · Reply
CasinosOfferFreeDrinks
CasinosOfferFreeDrinks May. 18 at 10:17 PM
$CMPS $CURLF $MSOS $SNDL $TCNNF poor doggies are going to be out of work unless ICE employs them at polling stations.
1 · Reply
Beowulfdragonslayer
Beowulfdragonslayer May. 18 at 10:06 PM
$CMPS looks like a good time to buy
0 · Reply
Waldo_5150
Waldo_5150 May. 18 at 8:38 PM
$CMPS ........ Johnson & Johnson owns the Treatment Centers Compass will be using (7,500) - With a small Stock share count , J.J. could buy or take a stake in Compass. ....
2 · Reply